Dr. Qing Li is a physician-scientist dedicated to advancing patient stratification and precision medicine in clinical development. With a unique combination of scientific excellence, extensive translational science experience, and expertise in diagnostic pathology, she is committed to accelerating drug development and bringing the right medicine to the right patients. 

She has a proven track record in clinical biomarker and companion diagnostic (CDx) development, successfully implementing end-to-end strategies to support clinical-stage drug development. Her expertise spans emerging technology platforms, including multi-omics and AI applications, to enhance the efficiency of biomarker discovery, clinical validation, and regulatory strategy.